DuoBody-CD3x5T4 is hypothesized to cross-link CD3ε-expressing T cells with 5T4-expressing tumor cells, thereby inducing T cell–mediated kill of 5T4-expressing tumor cells, associated with T-cell activation, T-cell proliferation, and production of inflammatory mediators and effector molecules. This evidence concerns the gene CD3E and neoplasm.